SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Reproductive Sciences
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kato, S.
Right arrow Articles by Cuello, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kato, S.
Right arrow Articles by Sadarangani, A.
Right arrow Articles by Lange, S.
Right arrow Articles by Delpiano, A. M.
Right arrow Articles by Vargas, M.
Right arrow Articles by Brañes, J.
Right arrow Articles by Carvajal, J.
Right arrow Articles by Lipkowitz, S.
Right arrow Articles by Owen, G. I.
Right arrow Articles by Cuello, M. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Medline Plus Health Information
*Ovarian Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

2-Methoxyestradiol Mediates Apoptosis Through Caspase-Dependent and Independent Mechanisms in Ovarian Cancer Cells But Not in Normal Counterparts

Sumie Kato

Department of Obstetrics and Gynecology, Faculty of Medicine, Universidad Católica de Chile, Santiago, Chile

Anil Sadarangani, PhD

Department of Physiology, Faculty of Biological Sciences Pontificia, Universidad Católica de Chile, Santiago, Chile

Soledad Lange

Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile

Ana M. Delpiano

Department of Obstetrics and Gynecology, Faculty of Medicine, Universidad Católica de Chile, Santiago, Chile

Macarena Vargas

Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile

Jorge Brañes, MD

Department of Obstetrics and Gynecology, Faculty of Medicine, Universidad Católica de Chile, Santiago, Chile

Jorge Carvajal, MD, PhD

Department of Obstetrics and Gynecology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Stanley Lipkowitz, MD, PhD

Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Institute of Cancer, National Institutes of Health, Bethesda, Maryland

Gareth I. Owen, PhD

Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile

Mauricio A. Cuello, MD

Department of Obstetrics and Gynecology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile, macuello{at}med.puc.cl

Objective: The estrogen metabolite 2-methoxyestradiol has shown antitumorigenic action in some epithelial tumors. In the present work we investigate its effects in ovarian cancer used alone or in combination with other apoptotic-inducing reagents such as tumor necrosis factor-related apoptosis-inducing ligand. Methods: To assess the effect of 2-methoxyestradiol, dose response and time courses in ovarian cancer and normal cells were conducted. Apoptosis was confirmed through DNA laddering, by flow cytometry, and Western blotting of proteins involved in the apoptotic cascade. Results: 2-Methoxyestradiol induced apoptosis in ovarian cancer cells but not in normal counterparts. 2-Methoxyestradiol activates both the intrinsic and extrinsic apoptotic pathways. 2-Methoxyestradiol—mediated apoptosis involves reactive oxygen species generation and caspase-dependent and caspase-independent mechanisms. We also demonstrate that 2-methoxyestradiol selectively induces an additive/synergistic apoptotic response in ovarian cancer cells when used in combination with tumor necrosis factor-related apoptosis-inducing ligand. Conclusions: 2-Methoxyestradiol, alone or in combination with tumor necrosis factor-related apoptosis-inducing ligand, should be considered as a potential treatment for ovarian cancer.

Key Words: AIF • 2ME • TRAIL • death receptors • chemotherapy • ovarian cancer.

Reproductive Sciences, Vol. 15, No. 9, 878-894 (2008)
DOI: 10.1177/1933719108324171


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
Y. S. Chua, Y. L. Chua, and T. Hagen
Structure Activity Analysis of 2-Methoxyestradiol Analogues Reveals Targeting of Microtubules as the Major Mechanism of Antiproliferative and Proapoptotic Activity
Mol. Cancer Ther., January 1, 2010; 9(1): 224 - 235.
[Abstract] [Full Text] [PDF]



Advertisement